Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.07. | Zomedica Corp.: The United States Eventing Association Names Zomedica's PulseVet as the Official Shock Wave of the USEA | 190 | ACCESSWIRE | Zomedica will sponsor a variety of high-profile events within the USEA ANN ARBOR, MI / ACCESSWIRE / July 17, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health... ► Artikel lesen | |
09.07. | Zomedica Corp.: Zomedica Expands Global Reach Through Strategic Alliance with Leader Healthcare Group for Sales Expansion in Key International Markets | 380 | ACCESSWIRE | Leader Healthcare Group is Chosen as Distribution Partner to Launch Zomedica® Products into the Gulf Cooperation Council Countries in the Middle East & North Africa (MENA), and India ANN ARBOR, MI /... ► Artikel lesen | |
03.07. | Zomedica Corp. - S-8, Securities to be offered to employees in employee benefit plans | 1 | SEC Filings | ||
01.07. | Zomedica Corp.: US Equestrian Names Zomedica's PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians | 233 | ACCESSWIRE | PulseVet® Shock Wave Device Supports Equine Athletes Ahead of Major International Team Events ANN ARBOR, MI / ACCESSWIRE / July 1, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company")... ► Artikel lesen | |
27.06. | Zomedica Corp.: Zomedica Expands TRUFORMA Addressable Market with Launch of Equine Cortisol Assay for the Platform | 248 | ACCESSWIRE | First-of-its-kind stall-side testing to enable rapid, life-saving decisions for equine veterinarians ANN ARBOR, MI / ACCESSWIRE / June 27, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the... ► Artikel lesen | |
25.06. | Zomedica Corp.: Zomedica Expands Market Opportunity for the TRUFORMA Point-of-Care Diagnostic Platform by Securing CE Mark | 209 | ACCESSWIRE | CE mark enables launch of the TRUFORMA® Diagnostic Platform into the European UnionANN ARBOR, MI / ACCESSWIRE / June 25, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary... ► Artikel lesen | |
10.06. | Zomedica Corp.: Zomedica to Present at the Sidoti Small Cap Conference June 12, 2024 | 169 | ACCESSWIRE | ANN ARBOR, MI / ACCESSWIRE / June 10, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products... ► Artikel lesen | |
07.06. | Zomedica Corp. - 8-K, Current Report | 2 | SEC Filings | ||
06.06. | Zomedica Corp.: Zomedica Announces Presentation of Compelling TRUFORMA Research Findings and Educational Programs at Major Veterinary Internal Medicine Conference | 219 | ACCESSWIRE | New research data confirms superiority of TRUFORMA's Bulk Acoustic Wave Sensor technology in diagnosing feline hyperthyroidism ANN ARBOR, MI / ACCESSWIRE / June 6, 2024 / Zomedica Corp. (NYSE American:ZOM)... ► Artikel lesen | |
04.06. | Zomedica increases manufacturing capacity | 1 | Seeking Alpha | ||
04.06. | Zomedica Corp.: Zomedica Increases Manufacturing Capacity with Expansion of its Roswell, Georgia Facility; Can Support Production to Five times Current Levels | 194 | ACCESSWIRE | Timely expansion enhances capacity amidst rapid sales growth ANN ARBOR, MI / ACCESSWIRE / June 4, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company... ► Artikel lesen | |
29.05. | Zomedica Corp.: Zomedica Enhances TRUFORMA Platform With Launch of Advanced Canine Cortisol Assay | 299 | ACCESSWIRE | Improved precision and greater accuracy of heavily used assay strengthens market potential for flagship in-clinic diagnostic platformANN ARBOR, MI / ACCESSWIRE / May 29, 2024 / Zomedica Corp. (NYSE... ► Artikel lesen | |
23.05. | Zomedica Corp.: Zomedica Publishes White Paper Highlighting Expanded Market Opportunities for PulseVet Therapy | 265 | ACCESSWIRE | Data supports expanding use of PulseVet Shock Wave therapy to treat equine EIPH and equine asthma ANN ARBOR, MI / ACCESSWIRE / May 23, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company")... ► Artikel lesen | |
21.05. | Zomedica Corp.: Zomedica to Present at the Lytham Partners Spring 2024 Investor Conference on May 30, 2024 | 206 | ACCESSWIRE | ANN ARBOR, MI / ACCESSWIRE / May 21, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products... ► Artikel lesen | |
15.05. | Zomedica Corp.: Zomedica Releases Over-the-Air Software Update Capabilities for Its TRUFORMA Platform | 335 | ACCESSWIRE | OTA capability enhances introduction of new assays from rapidly expanding menuANN ARBOR, MI / ACCESSWIRE / May 15, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary... ► Artikel lesen | |
14.05. | Zomedica And 3 Other Stocks Under $3 Insiders Are Buying | 2 | Benzinga.com | ||
10.05. | Zomedica Corp. (ZOM) Q1 2024 Earnings Call Transcript | 1 | Insider Monkey | ||
09.05. | Zomedica Corp.: Zomedica Announces First Quarter 2024 Financial Results: Revenue up 14% to $6.3 Million; 66% Gross Margin, and $91 Million in Liquidity | 355 | ACCESSWIRE | Performance Sets New Record for First Quarter RevenueANN ARBOR, MI / ACCESSWIRE / May 9, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering... ► Artikel lesen | |
09.05. | Zomedica Corp. - 8-K, Current Report | 2 | SEC Filings | ||
09.05. | Zomedica Corp. - 10-Q, Quarterly Report | 2 | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FRESENIUS | 31,860 | 0,00 % | Fresenius: Dank defensiver Qualitäten zum Outperformer | Die Aktie von Fresenius hat sich zuletzt als einer der Outperformer im DAX entpuppt. Charttechnisch sieht es jetzt spannend aus. Der Kurs steht direkt vor einer wichtigen Hürde und könnte mittelfristig... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 53,30 | +0,38 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers vor Quartalszahlen auf "Overweight" mit einem Kursziel von 72,90 Euro belassen. Seine Prognosen für Umsatz... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 37,180 | -1,51 % | Kurs der FMC-Aktie verharrt auf Vortags-Niveau (52,8534 €) | Der Kurs der dem Anteilsschein von FMC kommt kaum von der Stelle. Die Aktie notiert aktuell bei 57,55 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich gegenwärtig... ► Artikel lesen | |
CARL ZEISS MEDITEC | 61,70 | +1,98 % | RBC stuft CARL ZEISS MEDITEC AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Carl Zeiss Meditec auf "Outperform" mit einem Kursziel von 85 Euro belassen. Bei den anstehenden Zahlen der europäischen Medizintechnik-Unternehmen... ► Artikel lesen | |
GERRESHEIMER | 93,75 | +1,46 % | JPMORGAN stuft GERRESHEIMER AG auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Gerresheimer auf "Overweight" mit einem Kursziel von 121,80 Euro belassen. Dass der US-Branchenkollege West Pharma enttäuschende Quartalszahlen... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
CAREMAX | 6,420 | +13,83 % | HotStocks USA: +27 % bei CareMax, - 28 % bei MaxLinear | ||
BRIGHTSPRING HEALTH SERVICES | 12,330 | +1,99 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Definitive Agreement to Acquire Haven, Expanding Its Hospice Services into the CON State of Florida | LOUISVILLE, Ky., June 24, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ: BTSG), a leading provider of home and community-based health services for... ► Artikel lesen | |
PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report | ||
TEMPUS AI | 41,920 | +4,75 % | wO Börsenlounge: Eli Lilly | Tempus AI | BP & Rechenzentrenperle aus Schweden | Rechenzentren schießen wie Pilze aus dem Boden. Die Nachfrage ist groß, da KI-Modelle schließlich richtig viel Rechenpower brauchen. Die üblichen Verdächtigen sind wieder angesprungen. Eine Perle aus... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 8,930 | -4,59 % | Critical Insights From Alignment Healthcare Analyst Ratings: What You Need To Know | ||
RXSIGHT | 44,500 | -1,77 % | RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 | ||
GENEDX | 33,530 | +2,48 % | GeneDx Holdings Corp.: GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients | -- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections -- -- Increases commercial footprint and focus on accelerating... ► Artikel lesen | |
DEXCOM | 58,84 | -0,15 % | Kaum Impulse für die Dexcom-Aktie (102,3438 €) | Im US-amerikanischen Wertpapierhandel ist das Wertpapier von Dexcom gegenwärtig unauffällig. Die Aktie notiert derzeit bei 111,35 US-Dollar. Wenig getan hat sich heute bislang beim Kurs von Dexcom.... ► Artikel lesen | |
ATRICURE | 22,120 | -5,99 % | AtriCure (ATRC) Gains China Approval for AtriClip LAA System |